Showing results (1-10 of 719) with videos related to
Sort By:
Pageof 72
Seminars in Hematology|June 26, 2012
Bortezomib combination therapy in multiple myelomaPrashant Kapoor, Vijay Ramakrishnan, S Vincent RajkumarInternational Journal of Hematology|October 19, 2011
Update on risk stratification and treatment of newly diagnosed multiple myelomaPrashant Kapoor, S Vincent RajkumarCancer Journal (Sudbury, Mass.)|January 30, 2019
Smoldering Multiple Myeloma: To Treat or Not to TreatPrashant Kapoor, S Vincent RajkumarBlood Reviews|September 2, 2023
Current approach to Waldenström macroglobulinemiaPrashant Kapoor, S Vincent RajkumarLeukemia Research|October 6, 2014
Multiple mechanisms contribute to the synergistic anti-myeloma activity of the pan-histone deacetylase inhibitor LBH589 and the rapalog RAD001Vijay Ramakrishnan, Teresa Kimlinger, Michael Timm, et al.British Journal of Haematology|March 6, 2008
Anti-CD20 monoclonal antibody therapy in multiple myelomaPrashant Kapoor, Patricia T Greipp, William G Morice, et al.Plos One|November 28, 2012
Anti-myeloma activity of Akt inhibition is linked to the activation status of PI3K/Akt and MEK/ERK pathwayVijay Ramakrishnan, Teresa Kimlinger, Jessica Haug, et al.Blood Cancer Journal|February 10, 2021
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS)Li Pang, S Vincent Rajkumar, Prashant Kapoor, et al.Blood Cancer Journal|July 30, 2020
In vitro and ex vivo gene expression profiling reveals differential kinetic response of HSPs and UPR genes is associated with PI resistance in multiple myelomaAmit Kumar Mitra, Harish Kumar, Vijay Ramakrishnan, et al.Oncotarget|August 6, 2016
Smac mimetic LCL161 overcomes protective ER stress induced by obatoclax, synergistically causing cell death in multiple myelomaVijay Ramakrishnan, Marcus Gomez, Vivek Prasad, et al.Pageof 72